黑料官网

header-logo
GettyImages-609179959-hero
headshot

Binod Dhakal, MD

Associate Professor

view provider profile

Locations

  • Froedtert Hospital
  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English, Nepali, Hindi

Clinical Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine

Biography

Binod Dhakal, MD, MS, is Assistant Professor of Medicine, at the 黑料官网, Division of Hematology, specializing in multiple myeloma and plasma cell disorders. He graduated from Manipal College of Medical Sciences, Pokhara Nepal in 2004, completed Internal Medicine Residency at Saint Francis Hospital Evanston Illinois, and a fellowship in hematology/oncology at the 黑料官网, where he also served as a Chief Fellow. Prior to joining the fellowship, he was Assistant Professor of Medicine at the Medical College in Wisconsin in the Division of General Internal Medicine. He has authored numerous publications, including journal articles, meeting abstracts and book chapters. He has also won several awards during his fellowship which include the American Society of Clinical Oncology (ASCO) Merit Award; 黑料官网 Affiliated Hospitals (黑料官网AH) research award; Central Society for Clinical and Translational Research (CSCTR) best oral abstract and travel trainee award; American Society for Blood and Marrow Transplantation (ASBMT) clinical research training course; and, Outstanding Medical School Teacher award. Additionally, he was the recipient of the Mazie Froedtert Willms and Sue Froedtert Cancer Scholarship, and obtained his Master’s Degree in Clinical and Translational Science.

Research Interests

Dr. Dhakal's current research interests focus on novel drug treatments for patients with multiple myeloma and related plasma cell disorders by designing and conducting early phase clinical trials.

Publications

  • (Chari A, Costello C, Krishnan A, Patel K, Banerjee R, Berdeja JG, Biran N, Callander N, Costa LJ, Dhakal B, Gasparetto C, Hansen DK, Kumar A, Nooka AK, Pan D, Richard S.) Am J Hematol. 2026 Apr 21 PMID: 42014940 04/22/2026

  • (Bal S, Ravi G, Dhakal B, Callander NS, Medvedova E, Dholaria BR, Giri S, Godby KN, Silbermann RW, Mikhail FM, Huls F, Reddy V, Costa LJ.) Blood. 2026 Apr 16;147(16):1857-1862 PMID: 41592281 SCOPUS ID: 2-s2.0-105033982851 01/27/2026

  • (Hansen DK, Dima D, Mian H, Devos J, Brazauskas R, Oloyede T, Afrough A, Ahmed N, Anderson L, Banerjee R, Berdeja JG, Bidikian A, Dhakal B, Dias A, Efebera Y, Faisal MS, Gowda L, Hashmi H, Mirza AS, Mohan M, Narra R, Rosko AE, Schroeder M, Nishihori T, Landau H, Usmani S, Pasquini MC, Akhtar OS, Sidana S, Patel KK.) Blood Cancer J. 2026 Apr 14 PMID: 41980929 04/15/2026

  • (Dhakal B, Levy MY, Ko G, He J, Kim N, Tang W, Le Blanc T, Fowler J, Lucht S, Brown M, Bland E, Craig C, Giegerich S, Laney J, Feinberg B, Gupta-Werner N, Kaila S, Voorhees P.) Oncol Ther. 2026 Mar 26 PMID: 41886245 03/26/2026

  • (Ailawadhi S, Hansen DK, Dhakal B, Shune LO, Anderson LD Jr, De Braganca KC, Lengil T, Alegria V, Perciavalle M, Lu JH, Sacchi E, Lee S, Emond B, Huo S, Bixby T, Qureshi ZP, Sborov DW.) Adv Ther. 2026 Mar 24 PMID: 41874852 SCOPUS ID: 2-s2.0-105034404819 03/24/2026

  • (Varga C, Robinson M, Davis JA, Hashmi H, Martin TG, Kumar A, Sborov DW, Wagner CB, Hansen DK, Castaneda Puglianini O, Shune L, Bhurtel E, Afrough A, Anderson LD Jr, Dhakal B, Herr MM, Richard S, Lieberman-Cribbin A, Sherbenou D, Forsberg PA, Purvey S, Khouri J, Lin Y, Sidana S, Patel KK, Kocoglu M, Midha S, Ferreri CJ.) Blood Cancer J. 2026 Mar 20;16(1) PMID: 41862439 PMCID: PMC13018517 SCOPUS ID: 2-s2.0-105033651563 03/21/2026

  • (Al Hadidi S, Costello C, Costa LJ, Dhakal B, Georges P, Gajra A, Lin Y, Bhargava RS, Paner-Straseviciute A, Vij R.) Clin Lymphoma Myeloma Leuk. 2026 Mar 17 PMID: 41936482 04/06/2026

  • (Aughey E, Estrada-Merly N, Akhtar OS, Dhakal B, Mohan M, Narra R, Pasquini MC, D'Souza A.) Br J Haematol. 2026 Mar 09 PMID: 41797476 03/09/2026

  • (Venkatesh P, Ravi G, Dhakal B, Callander NS, Medvedova E, Dholaria BR, Giri S, Godby KN, Silbermann RW, Mikhail FM, Huls F, Reddy V, Costa LJ, Bal S.) Br J Haematol. 2026 Mar;208(3):1001-1008 PMID: 41693283 SCOPUS ID: 2-s2.0-105030173566 02/16/2026

  • (Mohan M, Danziger N, Akhtar OS, Narra R, Pasquini MC, Radhakrishnan S, Dhakal B, D'Souza A, Lin D, Ho C, Kurzrock R.) Blood Adv. 2026 Feb 24;10(4):1400-1404 PMID: 41733946 02/24/2026

  • (Arsang-Jang S, Massat B, Pareek G, Han J, Thapa B, Patek V, Nader Z, Auer PL, Zimmerman MT, Urrutia R, Hari P, D'Souza A, Dhakal B, Janz S, Dong J.) HLA. 2026 Feb;107(2):e70589 PMID: 41685425 PMCID: PMC12902906 SCOPUS ID: 2-s2.0-105029925738 02/13/2026

  • (Zhou K, Ebben L, Dhakal B, Vallatharasu Y.) JCO Oncol Pract. 2026 Jan 13:OP2500748 PMID: 41529233 01/13/2026

Publications of from the

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.